To meet surging demand, many companies rely on compounded semaglutide - unapproved versions of the active ingredient in Ozempic and Wegovy - produced by third-party pharmacies
Potential side effects are nausea, vomiting, heartburn, stomach ulcer, gastrointestinal bleeding, and kidney injury
The Mounjaro label includes warnings for severe gastrointestinal adverse reactions, acute kidney injury due to volume depletion, acute gallbladder disease, and diabetic retinopathy complications in certain patients
They serve different purposes: oral precursors for daily maintenance, IV for therapeutic protocols
The goal is to introduce the liquid as gently as possible
Healthier cells translate into a stronger, more resilient body overall